Agranulocytosis and neutropenia with typical and atypical neuroleptics.
Hong
X
X
Wang
X
X
D000328:Adult; D000380:Agranulocytosis / Q000097:blood / Q000139:chemically induced* / Q000453:epidemiology; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D009503:Neutropenia / Q000097:blood / Q000139:chemically induced* / Q000453:epidemiology; D000077152:Olanzapine; D010546:Perphenazine / Q000009:adverse effects / Q000627:therapeutic use; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D010546:Perphenazine; D003024:Clozapine; D018967:Risperidone; D000077152:Olanzapine